Favourable outcome of severe COVID-19 patients in hyperinflammatory phase with high dose dexamethasone pulse therapy: A series of 10 cases.
J Family Med Prim Care
; 10(12): 4598-4604, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1689980
ABSTRACT
The hyperinflammatory phase of COVID-19 occurring because of cytokine storm is the leading cause of mortality and morbidity in the affected patients. Various drugs with no definite cure are being tried to tackle the cytokine storm. Recently high dose corticosteroids are being used to arrest the surge of cytokines. In the current case series, we will be discussing the outcome of high dose dexamethasone pulse therapy in 10 cases of COVID-19 in hyperinflammatory phase who were cured of the disease along with improvement in laboratory parameters without any complications to the therapy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
J Family Med Prim Care
Year:
2021
Document Type:
Article
Affiliation country:
Jfmpc.jfmpc_963_21
Similar
MEDLINE
...
LILACS
LIS